Ronald B Moss

Summary

Publications

  1. pmc A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection
    Ronald B Moss
    NexBio Inc, San Diego California 92121, USA
    J Infect Dis 206:1844-51. 2012
  2. doi Targeting pandemic influenza: a primer on influenza antivirals and drug resistance
    Ronald B Moss
    NexBio, Inc, San Diego, CA, USA
    J Antimicrob Chemother 65:1086-93. 2010
  3. pmc Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein
    Gallen B Triana-Baltzer
    NexBio Inc, San Diego, CA, USA
    PLoS ONE 4:e7838. 2009
  4. pmc Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients
    Ronald B Moss
    NexBio Inc, 10665 Sorrento Valley Road, San Diego, CA 92121, USA
    Adv Virol 2011:910930. 2011
  5. pmc Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein
    Gallen B Triana-Baltzer
    NexBio Inc, San Diego, CA, USA
    PLoS ONE 4:e7788. 2009

Collaborators

Detail Information

Publications5

  1. pmc A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection
    Ronald B Moss
    NexBio Inc, San Diego California 92121, USA
    J Infect Dis 206:1844-51. 2012
    ..DAS181, a novel host-directed antiviral in development for influenza treatment, was assessed in this phase II clinical trial...
  2. doi Targeting pandemic influenza: a primer on influenza antivirals and drug resistance
    Ronald B Moss
    NexBio, Inc, San Diego, CA, USA
    J Antimicrob Chemother 65:1086-93. 2010
    ..In this review, we will summarize the effects of the currently licensed anti-influenza drugs as well as the candidates in development against the seasonal and the 2009 H1N1 pandemic influenza A virus with an emphasis on drug resistance...
  3. pmc Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein
    Gallen B Triana-Baltzer
    NexBio Inc, San Diego, CA, USA
    PLoS ONE 4:e7838. 2009
    ..DAS181 inhibits IFV that is resistant to NAIs. Thus, DAS181 may offer an alternative therapeutic option for seasonal or pandemic IFVs that become resistant to currently available antiviral drugs...
  4. pmc Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients
    Ronald B Moss
    NexBio Inc, 10665 Sorrento Valley Road, San Diego, CA 92121, USA
    Adv Virol 2011:910930. 2011
    ..The development of effective new therapies for influenza and parainfluenza in these high-risk patients is needed with randomized placebo-controlled studies to assess their clinical utility...
  5. pmc Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein
    Gallen B Triana-Baltzer
    NexBio Inc, San Diego, CA, USA
    PLoS ONE 4:e7788. 2009
    ..Here, we use in vitro, ex vivo, and in vivo models to evaluate the activity of DAS181 against several pandemic influenza A(H1N1) viruses...